Ads
related to: dapagliflozin for diabetics patients treatmentexplorefrog.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
New Phase III Data Showed Dapagliflozin Significantly Reduced HbA1c Compared to Placebo at 24 Weeks in Patients with Type 2 Diabetes Inadequately Controlled with the Combination of Metformin Plus ...
Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment
Dapagliflozin is an example of an SGLT-2 inhibitor, it is a competitive, highly selective inhibitor of SGLT. It acts via selective and potent inhibition of SGLT-2, and its activity is based on each patient's underlying blood sugar control and kidney function. The results are decreased kidney reabsorption of glucose, glucosuria effect increases ...
The SGLT2 inhibitor dapagliflozin has been indicated for the treatment of type 2 diabetes since 2012. ... an adjunct to insulin in patients with type 1 diabetes with a body-mass index (BMI) of 27 ...
In the European Union, it is indicated in adults aged 18 years and older with type 2 diabetes: to improve glycemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycemic control. [3] when already being treated with saxagliptin and dapagliflozin. [3]
Diabetes medications: Insulin and thiazolidinediones. Beta-blockers: Propranolol and metoprolol. Glucocorticoids: Prednisone and cortisone. If your health depends on these medications, ask your ...
Ads
related to: dapagliflozin for diabetics patients treatmentexplorefrog.com has been visited by 10K+ users in the past month